Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression

pubmed: wnt1 2021-06-25

Summary:

CONCLUSIONS: We propose that galectin-3 mediates the crosstalk between the WNT and STAT3 signaling pathways. Therefore GB1107, a galectin-3-specific inhibitor, maybe a potent agent with anti-gastric cancer activity. Further studies are needed for its clinical application in gastric cancer therapy.

Link:

https://pubmed.ncbi.nlm.nih.gov/33834359/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=16uwQpOeqFYN8R4TKOtwPy2utpqy9ex2oldalD2yF_fQHv2caq&fc=None&ff=20210625115200&v=2.14.4

From feeds:

Exome » pubmed: wnt1

Authors:

Seok-Jun Kim, Hyeok-Gu Kang, Kyungeun Kim, Hoyoung Kim, Fredrik Zetterberg, Young Soo Park, Hyun-Soo Cho, Stephen M Hewitt, Joon-Yong Chung, Ulf J Nilsson, Hakon Leffler, Kyung-Hee Chun

Date tagged:

06/25/2021, 12:43

Date published:

04/09/2021, 06:00